Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

YM 466

Known as: YM-466, YM466 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The aim of this study was to find out polymeric compounds that can inhibit the interaction between YM466, a novel anticoagulant… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
SummaryThe pharmacokinetics of YM466, a selective inhibitor for factor Xa, was investigated after single intravenous and oral… Expand
  • figure 3
  • figure 4
2010
2010
SummaryYM466, a novel factor Xa inhibitor, is a hydrophilic compound with a carboxylic acid moiety. Previous studies in rats have… Expand
  • table I
  • figure 1
  • figure 2
2007
2007
A simple, quantitative, and reproducible model of lower limb ischemia was developed. Vascular injury was induced by ferric… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
Thrombosis and neointima formation limit the efficacy of coronary angioplasty. Factor Xa inhibitors and GPIIb/IIIa antagonists… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
YM466 is a novel factor Xa inhibitor for the treatment of thrombosis. The absorption, distribution, metabolism and excretion of… Expand
2004
2004
A sensitive and selective method for the determination of YM466, a novel Factor Xa inhibitor, in rat plasma was developed and… Expand
2003
2003
Abstract Various solubilizing agents for YM466, a new Factor Xa inhibitor, were investigated to begin designing the aqueous… Expand
2003
2003
The antithrombotic effects of YM466, a synthetic direct inhibitor of human factor Xa (FXa), were evaluated in an arterio‐venous… Expand
2002
2002
A specific method for the determination of YM466, a novel Factor Xa inhibitor, in rat and dog plasma was developed and validated… Expand